Dror Tobi

2.0k total citations
40 papers, 1.6k citations indexed

About

Dror Tobi is a scholar working on Molecular Biology, Cell Biology and Materials Chemistry. According to data from OpenAlex, Dror Tobi has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Materials Chemistry. Recurrent topics in Dror Tobi's work include Protein Structure and Dynamics (18 papers), Enzyme Structure and Function (8 papers) and RNA and protein synthesis mechanisms (7 papers). Dror Tobi is often cited by papers focused on Protein Structure and Dynamics (18 papers), Enzyme Structure and Function (8 papers) and RNA and protein synthesis mechanisms (7 papers). Dror Tobi collaborates with scholars based in Israel and United States. Dror Tobi's co-authors include İvet Bahar, Ron Elber, Chakra Chennubhotla, Chunyan Xu, Daphné Atlas, Michael Trus, Ofer Wiser, Devarajan Thirumalai, Nathan Linial and Sarah Halevi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Dror Tobi

40 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dror Tobi Israel 16 1.4k 512 232 197 162 40 1.6k
James O. Wrabl United States 18 1.9k 1.4× 600 1.2× 205 0.9× 235 1.2× 256 1.6× 41 2.2k
Ernesto J. Fuentes United States 23 1.5k 1.1× 487 1.0× 369 1.6× 174 0.9× 207 1.3× 43 1.7k
Hesam N. Motlagh United States 7 1.2k 0.9× 334 0.7× 145 0.6× 195 1.0× 162 1.0× 8 1.5k
Charalampos G. Kalodimos United States 17 2.1k 1.5× 588 1.1× 242 1.0× 272 1.4× 353 2.2× 28 2.4k
Razif R. Gabdoulline Germany 23 1.7k 1.3× 433 0.8× 179 0.8× 168 0.9× 95 0.6× 37 2.2k
Sarah L. Shammas United Kingdom 21 1.7k 1.3× 520 1.0× 272 1.2× 86 0.4× 121 0.7× 30 2.0k
Felix B. Sheinerman United States 12 1.3k 1.0× 542 1.1× 100 0.4× 158 0.8× 142 0.9× 12 1.5k
Andreas Vitalis Switzerland 22 2.1k 1.5× 759 1.5× 143 0.6× 143 0.7× 263 1.6× 46 2.4k
Jens Danielsson Sweden 30 1.7k 1.2× 364 0.7× 157 0.7× 250 1.3× 264 1.6× 53 2.6k
Michael W. Clarkson United States 18 1.2k 0.9× 392 0.8× 112 0.5× 88 0.4× 228 1.4× 24 1.5k

Countries citing papers authored by Dror Tobi

Since Specialization
Citations

This map shows the geographic impact of Dror Tobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Tobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Tobi more than expected).

Fields of papers citing papers by Dror Tobi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Tobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Tobi. The network helps show where Dror Tobi may publish in the future.

Co-authorship network of co-authors of Dror Tobi

This figure shows the co-authorship network connecting the top 25 collaborators of Dror Tobi. A scholar is included among the top collaborators of Dror Tobi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror Tobi. Dror Tobi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zipin‐Roitman, Adi, Dror Tobi, Andrii Bazylevich, et al.. (2025). Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia. Scientific Reports. 15(1). 10607–10607. 1 indexed citations
2.
Sharma, Vipin, Andrii Bazylevich, Dror Tobi, et al.. (2024). Synthesis and anticancer properties of novel dolastatin 10 analogs featuring five-membered heterocyclic rings with a linkable group at the C-terminus. Bioorganic & Medicinal Chemistry. 109. 117794–117794. 1 indexed citations
3.
Tobi, Dror, et al.. (2023). Different sea urchin RAG-like genes were domesticated to carry out different functions. Frontiers in Immunology. 13. 1066510–1066510. 1 indexed citations
4.
Tobi, Dror, et al.. (2022). Three-Dimensional Modeling of Thyroid Hormone Metabolites Binding to the Cancer-Relevant αvβ3 Integrin: In-Silico Based Study. Frontiers in Endocrinology. 13. 895240–895240. 4 indexed citations
5.
Tobi, Dror, et al.. (2022). The effect of dimerization and ligand binding on the dynamics of Kaposi's sarcoma‐associated herpesvirus protease. Proteins Structure Function and Bioinformatics. 90(6). 1267–1277. 3 indexed citations
6.
Tobi, Dror, et al.. (2019). Dynamical comparison between Drosha and Dicer reveals functional motion similarities and dissimilarities. PLoS ONE. 14(12). e0226147–e0226147. 6 indexed citations
7.
Tobi, Dror. (2018). Dynamics based clustering of globin family members. PLoS ONE. 13(12). e0208465–e0208465. 5 indexed citations
8.
Tobi, Dror. (2017). Dynamical differences of hemoglobin and the ionotropic glutamate receptor in different states revealed by a new dynamics alignment method. Proteins Structure Function and Bioinformatics. 85(8). 1507–1517. 6 indexed citations
9.
Kirby, Michael, Elimelech Nesher, Gary Gellerman, et al.. (2016). Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: antitumor activity in mouse melanoma models. Oncotarget. 7(39). 63549–63560. 11 indexed citations
10.
Tobi, Dror. (2010). Designing coarse grained-and atom based-potentials for protein-protein docking. BMC Structural Biology. 10(1). 40–40. 34 indexed citations
11.
Tobi, Dror, et al.. (2009). Docking of Antizyme to Ornithine Decarboxylase and Antizyme Inhibitor using Experimental Mutant and Double-Mutant Cycle Data. Journal of Molecular Biology. 390(3). 503–515. 19 indexed citations
12.
Tobi, Dror & İvet Bahar. (2007). Recruitment of rare 3-grams at functional sites: Is this a mechanism for increasing enzyme specificity?. BMC Bioinformatics. 8(1). 226–226. 3 indexed citations
13.
Tobi, Dror & İvet Bahar. (2005). Structural changes involved in protein binding correlate with intrinsic motions of proteins in the unbound state. Proceedings of the National Academy of Sciences. 102(52). 18908–18913. 304 indexed citations
14.
Tobi, Dror & İvet Bahar. (2005). Optimal design of protein docking potentials: Efficiency and limitations. Proteins Structure Function and Bioinformatics. 62(4). 970–981. 34 indexed citations
15.
Vries, John K., et al.. (2004). A Sequence Alignment-Independent Method for Protein Classification. PubMed. 3(2). 137–148. 15 indexed citations
16.
Niv, Masha Y., Jacob Cohen, Tamar Licht, et al.. (2004). Sequence-based Design of Kinase Inhibitors Applicable for Therapeutics and Target Identification. Journal of Biological Chemistry. 279(2). 1242–1255. 38 indexed citations
17.
Brisson, Marni, Theresa Nguyen, Andreas Vogt, et al.. (2004). Discovery and Characterization of Novel Small Molecule Inhibitors of Human Cdc25B Dual Specificity Phosphatase. Molecular Pharmacology. 66(4). 824–833. 63 indexed citations
18.
Xu, Chunyan, Dror Tobi, & İvet Bahar. (2003). Allosteric Changes in Protein Structure Computed by a Simple Mechanical Model: Hemoglobin T↔R2 Transition. Journal of Molecular Biology. 333(1). 153–168. 155 indexed citations
19.
Tobi, Dror, Ron Elber, & Devarajan Thirumalai. (2003). The dominant interaction between peptide and urea is electrostatic in nature: A molecular dynamics simulation study. Biopolymers. 68(3). 359–369. 94 indexed citations
20.
Tobi, Dror, et al.. (2000). On the design and analysis of protein folding potentials. Proteins Structure Function and Bioinformatics. 40(1). 71–85. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James O. Wrabl Breakdown of academic impact, for papers by Ernesto J. Fuentes Breakdown of academic impact, for papers by Hesam N. Motlagh Breakdown of academic impact, for papers by Charalampos G. Kalodimos Breakdown of academic impact, for papers by Razif R. Gabdoulline Breakdown of academic impact, for papers by Sarah L. Shammas Breakdown of academic impact, for papers by Felix B. Sheinerman Breakdown of academic impact, for papers by Andreas Vitalis Breakdown of academic impact, for papers by Jens Danielsson Breakdown of academic impact, for papers by Michael W. Clarkson
Rankless by CCL
2026